BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18769883)

  • 21. Proliferating cell nuclear antigen as a marker of cell kinetics in aberrant crypt foci, hyperplastic polyps, adenomas, and adenocarcinomas of the human colon.
    Shpitz B; Bomstein Y; Mekori Y; Cohen R; Kaufman Z; Grankin M; Bernheim J
    Am J Surg; 1997 Oct; 174(4):425-30. PubMed ID: 9337168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial.
    Hosono K; Endo H; Takahashi H; Sugiyama M; Sakai E; Uchiyama T; Suzuki K; Iida H; Sakamoto Y; Yoneda K; Koide T; Tokoro C; Abe Y; Inamori M; Nakagama H; Nakajima A
    Cancer Prev Res (Phila); 2010 Sep; 3(9):1077-83. PubMed ID: 20810669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The natural history of aberrant crypt foci.
    Schoen RE; Mutch M; Rall C; Dry SM; Seligson D; Umar A; Pinsky P
    Gastrointest Endosc; 2008 Jun; 67(7):1097-102. PubMed ID: 18178205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and quantification of aberrant crypt foci and microadenomas in the human colon.
    Roncucci L; Stamp D; Medline A; Cullen JB; Bruce WR
    Hum Pathol; 1991 Mar; 22(3):287-94. PubMed ID: 1706308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenotypic and genotypic characteristics of aberrant crypt foci in human colorectal mucosa.
    Nucci MR; Robinson CR; Longo P; Campbell P; Hamilton SR
    Hum Pathol; 1997 Dec; 28(12):1396-407. PubMed ID: 9416697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant crypt foci in human colons: distribution and histomorphologic characteristics.
    Shpitz B; Bomstein Y; Mekori Y; Cohen R; Kaufman Z; Neufeld D; Galkin M; Bernheim J
    Hum Pathol; 1998 May; 29(5):469-75. PubMed ID: 9596270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of Difluoromethylornithine and Aspirin for Treatment of Adenomas and Aberrant Crypt Foci in Patients with Prior Advanced Colorectal Neoplasms.
    Sinicrope FA; Velamala PR; Song LMWK; Viggiano TR; Bruining DH; Rajan E; Gostout CJ; Kraichely RE; Buttar NS; Schroeder KW; Kisiel JB; Larson MV; Sweetser SR; Sedlack RR; Sinicrope SN; Richmond E; Umar A; Della'Zanna G; Noaeill JS; Meyers JP; Foster NR
    Cancer Prev Res (Phila); 2019 Nov; 12(11):821-830. PubMed ID: 31484660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant crypt focus size predicts distal polyp histopathology.
    Kim J; Ng J; Arozulllah A; Ewing R; Llor X; Carroll RE; Benya RV
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1155-62. PubMed ID: 18483337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scanning electron microscopy of aberrant crypt foci in human colorectal mucosa.
    Vaccina F; Scorcioni F; Pedroni M; Tamassia MG; De Leon MP; De Pol A; Marzona L; Roncucci L
    Anticancer Res; 1998; 18(5A):3451-6. PubMed ID: 9858923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized Phase II Trial of Polyphenon E versus Placebo in Patients at High Risk of Recurrent Colonic Neoplasia.
    Sinicrope FA; Viggiano TR; Buttar NS; Song LMWK; Schroeder KW; Kraichely RE; Larson MV; Sedlack RE; Kisiel JB; Gostout CJ; Kalaiger AM; Patai ÁV; Della'Zanna G; Umar A; Limburg PJ; Meyers JP; Foster NR; Yang CS; Sontag S
    Cancer Prev Res (Phila); 2021 May; 14(5):573-580. PubMed ID: 33648940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Classification of aberrant crypt foci and microadenomas in human colon.
    Roncucci L; Medline A; Bruce WR
    Cancer Epidemiol Biomarkers Prev; 1991; 1(1):57-60. PubMed ID: 1845171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant crypt foci in human colon carcinogenesis.
    Dolara P; Caderni G; Lancioni L; Giannini A; Anastasi A; Fazi M; Castiglione G
    Cancer Detect Prev; 1997; 21(2):135-40. PubMed ID: 9101074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene expression patterns distinguish colonoscopically isolated human aberrant crypt foci from normal colonic mucosa.
    Glebov OK; Rodriguez LM; Soballe P; DeNobile J; Cliatt J; Nakahara K; Kirsch IR
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2253-62. PubMed ID: 17119054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The efficacy of aspirin and metformin combination therapy in patients with rectal aberrant crypt foci: a double-blinded randomized controlled trial.
    Higurashi T; Arimoto J; Ashikari K; Takatsu T; Misawa N; Yoshihara T; Matsuura T; Fuyuki A; Ohkubo H; Nakajima A
    BMC Cancer; 2020 Oct; 20(1):1043. PubMed ID: 33121471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of rectal aberrant crypt foci by standard chromoscopy and its predictive value for colonic advanced neoplasms.
    Seike K; Koda K; Oda K; Kosugi C; Shimizu K; Nishimura M; Shioiri M; Takano S; Ishikura H; Miyazaki M
    Am J Gastroenterol; 2006 Jun; 101(6):1362-9. PubMed ID: 16771962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for colorectal cancer in relation to number and size of aberrant crypt foci in humans.
    Rudolph RE; Dominitz JA; Lampe JW; Levy L; Qu P; Li SS; Lampe PD; Bronner MP; Potter JD
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):605-8. PubMed ID: 15767337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant crypt foci in the adenoma prevention with celecoxib trial.
    Cho NL; Redston M; Zauber AG; Carothers AM; Hornick J; Wilton A; Sontag S; Nishioka N; Giardiello FM; Saltzman JR; Gostout C; Eagle CJ; Hawk ET; Bertagnolli MM
    Cancer Prev Res (Phila); 2008 Jun; 1(1):21-31. PubMed ID: 19138933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysplastic Aberrant Crypt Foci: Biomarkers of Early Colorectal Neoplasia and Response to Preventive Intervention.
    Clapper ML; Chang WL; Cooper HS
    Cancer Prev Res (Phila); 2020 Mar; 13(3):229-240. PubMed ID: 32132117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced growth of colorectal aberrant crypt foci in fasted/refed rats involves changes in TGFbeta1 and p21CIP expressions.
    Caderni G; Perrelli MG; Cecchini F; Tessitore L
    Carcinogenesis; 2002 Feb; 23(2):323-7. PubMed ID: 11872640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of High-Risk Aberrant Crypt Foci and Mucin-Depleted Foci in the Human Colon With Study of Colon Cancer Stem Cell Markers.
    Gupta B; Das P; Ghosh S; Manhas J; Sen S; Pal S; Sahni P; Upadhyay AD; Panda SK; Gupta SD
    Clin Colorectal Cancer; 2017 Sep; 16(3):204-213. PubMed ID: 27789195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.